Friday, 4 December 2015

Who says our PBS scheme is inefficient?

Cancer-Drug Prices Vary Widely Even Among Countries With Curbs - Bloomberg Business:
  • "Gemzar costs five times more in New Zealand than in Australia 
  • Study limited by available information on cancer drug prices.
Even among countries with curbs on drug prices, the costs of cancer treatments vary widely, researchers wrote in the Lancet Oncology journal.

New Zealanders pay almost five times what Australians do for Eli Lilly & Co.’s Gemzar, used to treat breast, lung, pancreatic and ovarian cancers, according to the study of publicly available pricing information from 18 countries.

In Germany, Merck & Co.’s Intron A for skin and blood cancers costs triple what it does in Greece, the researchers found."

'via Blog this'
Post a Comment